Cornerstone Capital Management Holdings’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
Other funds holding IPXL
MC
FI
TG
Cornerstone Capital Management Holdings's IPXL Position: Q4 2017 in Review
Cornerstone Capital Management Holdings sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 29,100 shares — an estimated $590K sold.
Cornerstone Capital Management Holdings first reported a position in IPXL in Q2 2013 and held it in 18 quarters. The position peaked at $5.97M in Q3 2016. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.
- Cornerstone Capital Management Holdings reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
- Cornerstone Capital Management Holdings sold 29,100 Impax Laboratories, Inc. shares in Q4 2017, an estimated $590K.
- Cornerstone Capital Management Holdings first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 18 quarters.
- Cornerstone Capital Management Holdings's Impax Laboratories, Inc. position peaked at $5.97M in Q3 2016.
- 200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.
Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.